Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform
Open Access
- 5 April 2023
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 38 (5) , 573-586
Abstract
Treatment concepts in oncology are becoming increasingly personalized and diverse. Successively, changes in standards of care mandate continuous monitoring of patient pathways and clinical outcomes based on large, representative real-world data. The German Cancer Consortium’s (DKTK) Clinical Communication Platform (CCP) provides such opportunity. Connecting fourteen university hospital-based cancer centers, the CCP relies on a federated IT-infrastructure sourcing data from facility-based cancer registry units and biobanks. Federated analyses resulted in a cohort of 600,915 patients, out of which 232,991 were incident since 2013 and for which a comprehensive documentation is available. Next to demographic data (i.e., age at diagnosis: 2.0% 0–20 years, 8.3% 21–40 years, 30.9% 41–60 years, 50.1% 61–80 years, 8.8% 81+ years; and gender: 45.2% female, 54.7% male, 0.1% other) and diagnoses (five most frequent tumor origins: 22,523 prostate, 18,409 breast, 15,575 lung, 13,964 skin/malignant melanoma, 9005 brain), the cohort dataset contains information about therapeutic interventions and response assessments and is connected to 287,883 liquid and tissue biosamples. Focusing on diagnoses and therapy-sequences, showcase analyses of diagnosis-specific sub-cohorts (pancreas, larynx, kidney, thyroid gland) demonstrate the analytical opportunities offered by the cohort’s data. Due to its data granularity and size, the cohort is a potential catalyst for translational cancer research. It provides rapid access to comprehensive patient groups and may improve the understanding of the clinical course of various (even rare) malignancies. Therefore, the cohort may serve as a decisions-making tool for clinical trial design and contributes to the evaluation of scientific findings under real-world conditions.Keywords
All Related Versions
Funding Information
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
This publication has 26 references indexed in Scilit:
- Predicting the Future — Big Data, Machine Learning, and Clinical MedicineNew England Journal of Medicine, 2016
- Systematic review of intervention design and delivery in pragmatic and explanatory surgical randomized clinical trialsBritish Journal of Surgery, 2015
- A RESTful interface to pseudonymization services in modern web applicationsBMC Medical Informatics and Decision Making, 2015
- The rise of big clinical databasesBritish Journal of Surgery, 2015
- Exploiting Distributed, Heterogeneous and Sensitive Data Stocks while Maintaining the Owner’s Data SovereigntyMethods of Information in Medicine, 2015
- Veränderung von Inzidenz und Mortalität von Kopf-Hals-Malignomen in Rheinland-Pfalz, 2000–2009Laryngo-Rhino-Otologie, 2014
- DataSHIELD: taking the analysis to the data, not the data to the analysisInternational Journal of Epidemiology, 2014
- Review of methods used to measure comorbidity in cancer populations: No gold standard existsJournal of Clinical Epidemiology, 2012
- Voronoi Treemaps2005
- International rules for multiple primary cancers (ICD-0 third edition)European Journal Of Cancer Prevention, 2005